Top compounds associated with response to ADAM22


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.0007 1
mRNA Roscovitine FIMM pan-cancer AAC -0.004 1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0004 1
mRNA YM201636 GDSC1000 pan-cancer AAC -0.00011 1
mRNA QS11 CTRPv2 pan-cancer AAC -0.00024 1
mRNA Imatinib CTRPv2 pan-cancer AAC 5.9e-05 1
Download CSV